Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132740) titled 'A phase II clinical trial of ivonescimab induction chemoimmunotherapy followed by chemoradiotherapy or surgery for pulmonary lymphoepithelioma-like carcinoma' on Sept. 17.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Sun Yat-sen University Cancer Center
Condition:
Pulmonary lymphoepithelioma-like carcinoma
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2026-05-18
Target Sample Size: Treatment Group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=313491
Published by HT Digital Content Services wit...